This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Kalka-Moll, W. M.
Right arrow Articles by Vandamme, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalka-Moll, W. M.
Right arrow Articles by Vandamme, P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2009, p. 3026-3028, Vol. 47, No. 9
0095-1137/09/$08.00+0     doi:10.1128/JCM.00846-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Airway Infection with a Novel Cupriavidus Species in Persons with Cystic Fibrosis{triangledown}

Wiltrud Maria Kalka-Moll,1* John J. LiPuma,2 Frank J. Accurso,3 Georg Plum,1 Silke van Koningsbruggen,4 and Peter Vandamme5

Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne Medical Center, Cologne, Germany,1 Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan,2 Pulmonary Medicine/Cystic Fibrosis Center/Allergy, Children's Hospital of Denver, Denver, Colorado,3 Cystic Fibrosis Center Cologne, University Children's Hospital Cologne, University of Cologne Medical Center, Cologne, Germany,4 Laboratory of Microbiology, Ghent University, K. L. Ledeganckstraat 35, B-9000 Ghent, Belgium5

Received 28 April 2009/ Returned for modification 9 June 2009/ Accepted 21 June 2009

We describe the recovery and identification of a bacterium that represents a new species of the genus Cupriavidus from cultures of respiratory tract specimens from two patients with cystic fibrosis (CF). The elucidation of the role of this species in CF lung disease will require an evaluation of a greater number of cases.


* Corresponding author. Present address: MVZ Dr. Stein+Kollegen, Wallstrasse 10, 41061 Mönchengladbach, Germany. Phone: 49-2161-8194116. Fax: 49-2161-819450. E-mail: wkalkamoll{at}labor-stein.de

{triangledown} Published ahead of print on 15 July 2009.


Journal of Clinical Microbiology, September 2009, p. 3026-3028, Vol. 47, No. 9
0095-1137/09/$08.00+0     doi:10.1128/JCM.00846-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.